COLUMBIA, Md., Aug. 6, 2025 /PRNewswire/ -- Advarra, the market leader in regulatory reviews and a leading provider of clinical research technology, today announced a major expansion of its Study ...
New integrations with industry leaders in EDC, eConsent, IRT/RTSM, eCOA, payments, and patient engagement expands Advarra's connected ecosystem, giving sponsors, CROs, and research sites secure, ...
Entered into Clinical Study Collaboration and Supply Agreement with Gilead to evaluate IDE397, IDEAYA's MAT2A inhibitor, in combination with sacituzumab-govitecan-hziy ("Trodelvy") Gilead's Trop-2 ...
Project will identify genomic and epigenomic biomarkers in patient blood samples from PICI’s RADIOHEAD study using GuardantINFINITY™ Goal of mission-focused collaboration is to help accelerate ...
Economic and public health conditions influence universities' research priorities. A study led by INGENIO, a joint research center of the Spanish National Research Council (CSIC) and the Universitat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results